CTMX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $72,645.69

CytomX Therapeutics Insider Trading History Chart

CytomX Therapeutics Share Price & Price History

^$0.47

▲ +0.0129 (2.83%)

As of 04/9/2025 02:33 PM ET

Days: 30 | 90 | 365

CytomX Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2025	Christopher Ogden	CFO	Sell	8,551	$0.60	$5,130.60	201,026
3/18/2025	Lloyd A Rowland	General Counsel	Sell	10,203	$0.60	$6,121.80	120,594
3/18/2025	Marcia Belvin	SVP	Sell	19,512	$0.60	$11,707.20	248,636
3/18/2025	Sean A. McCarthy	CEO	Sell	37,656	$0.60	$22,593.60	995,195
3/18/2025	Yu-Waye Chu	Insider	Sell	4,025	$0.60	$2,415.00	135,725
8/20/2024	Christopher Ogden	CFO	Sell	1,984	$1.23	$2,440.32	108,077
8/20/2024	Jeffrey B Landau	Insider	Sell	4,181	$1.23	$5,142.63	119,056
8/20/2024	Sean A. McCarthy	CEO	Sell	13,898	$1.23	$17,094.54	657,851
3/19/2024	Christopher Ogden	SVP	Sell	2,971	$2.09	$6,209.39	85,686
3/19/2024	Jeffrey B Landau	Insider	Sell	6,562	$2.09	$13,714.58	110,060
3/19/2024	Lloyd A Rowland	General Counsel	Sell	5,268	$2.09	$11,010.12	117,728
3/19/2024	Sean A. McCarthy	CEO	Sell	20,223	$2.09	$42,266.07	524,481
12/20/2023	Marcia Belvin	SVP	Sell	4,077	$1.38	$5,626.26	155,124
12/20/2023	Sean A. McCarthy	CEO	Sell	13,551	$1.38	$18,700.38	454,704
9/22/2023	Lloyd A Rowland	General Counsel	Sell	5,486	$1.30	$7,131.80	80,609
9/22/2023	Marcia Belvin	SVP	Sell	4,119	$1.30	$5,354.70	147,951
9/22/2023	Sean A. McCarthy	CEO	Sell	14,601	$1.30	$18,981.30	430,755
3/29/2023	Elaine V Jones	Director	Buy	5,000	$1.55	$7,750.00	5,142
3/16/2023	Amy C Peterson	EVP	Sell	4,257	$1.98	$8,428.86	58,433
3/16/2023	Carlos Campoy	CFO	Sell	1,748	$1.98	$3,461.04	38,224
3/16/2023	Christopher Ogden	SVP	Sell	516	$1.98	$1,021.68	37,772
3/16/2023	Lloyd A Rowland	General Counsel	Sell	2,037	$1.98	$4,033.26	71,095
3/16/2023	Sean A. McCarthy	CEO	Sell	7,121	$1.88	$13,387.48	388,821
7/20/2022	Amy C Peterson	EVP	Sell	7,463	$1.42	$10,597.46	62,690
7/20/2022	Carlos Campoy	CFO	Sell	3,949	$1.42	$5,607.58	39,972
7/20/2022	Jeffrey B Landau	Insider	Sell	4,206	$1.42	$5,972.52	30,725
7/20/2022	Lloyd A Rowland	General Counsel	Sell	5,602	$1.42	$7,954.84	43,689
7/20/2022	Sean A. McCarthy	CEO	Sell	14,911	$1.42	$21,173.62	290,942

See Full Table

SEC Filings (Institutional Ownership Changes) for CytomX Therapeutics (NASDAQ:CTMX)

67.77% of CytomX Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CytomX Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/19/2025	Formidable Asset Management LLC	382,529	$0.39M	0.1%	+55.5%	0.489%
2/17/2025	Velan Capital Investment Management LP	35,000	$36K	0.0%	N/A	0.045%
2/17/2025	Two Sigma Investments LP	320,767	$0.33M	0.0%	-32.0%	0.410%
2/17/2025	Tidal Investments LLC	382,529	$0.39M	0.0%	+55.5%	0.489%
2/17/2025	Tang Capital Management LLC	7,311,760	$7.53M	0.5%	-6.4%	9.343%
2/17/2025	Point72 Asset Management L.P.	2,650,000	$2.73M	0.0%	N/A	3.386%
2/17/2025	Prosight Management LP	3,905,000	$4.02M	1.1%	+29.2%	4.990%
2/17/2025	Millennium Management LLC	3,221,012	$3.32M	0.0%	+25.8%	4.116%
2/17/2025	Jacobs Levy Equity Management Inc.	1,547,215	$1.59M	0.0%	+1.5%	1.977%
2/17/2025	Cubist Systematic Strategies LLC	98,383	$0.10M	0.0%	+302.2%	0.126%
2/17/2025	Bridgeway Capital Management LLC	331,624	$0.34M	0.0%	-7.0%	0.424%
2/17/2025	Algert Global LLC	33,570	$35K	0.0%	N/A	0.043%
2/17/2025	Aspire Growth Partners LLC	40,780	$42K	0.0%	N/A	0.052%
2/14/2025	Schonfeld Strategic Advisors LLC	1,380,800	$1.42M	0.0%	+13.9%	1.764%
2/14/2025	Northern Trust Corp	150,632	$0.16M	0.0%	+16.0%	0.192%
2/14/2025	Altium Capital Management LLC	467,491	$0.48M	0.1%	-48.9%	0.597%
2/13/2025	Renaissance Technologies LLC	1,346,800	$1.39M	0.0%	+32.7%	1.721%
2/13/2025	ADAR1 Capital Management LLC	145,036	$0.15M	0.0%	-84.0%	0.185%
2/13/2025	Russell Investments Group Ltd.	34,054	$35K	0.0%	-28.5%	0.044%
2/12/2025	JPMorgan Chase & Co.	811,630	$0.84M	0.0%	+288,736.3%	1.037%
2/11/2025	Prudential Financial Inc.	64,300	$66K	0.0%	+76.2%	0.082%
2/11/2025	Virtu Financial LLC	57,012	$59K	0.0%	-35.6%	0.073%
2/10/2025	Monimus Capital Management LP	364,306	$0.38M	0.4%	N/A	0.466%
2/7/2025	Miller Financial Services LLC	25,000	$26K	0.0%	N/A	0.032%
1/17/2025	Traphagen Investment Advisors LLC	30,500	$31K	0.0%	N/A	0.039%
1/15/2025	Congress Park Capital LLC	964,590	$0.99M	0.4%	-20.7%	1.233%
1/14/2025	Assenagon Asset Management S.A.	599,850	$0.62M	0.0%	-63.5%	0.766%
11/25/2024	Tidal Investments LLC	246,001	$0.29M	0.0%	-4.7%	0.314%
11/20/2024	Virtu Financial LLC	88,518	$0.10M	0.0%	N/A	0.113%
11/16/2024	Geode Capital Management LLC	803,531	$0.95M	0.0%	+4.4%	1.027%
11/15/2024	XTX Topco Ltd	43,664	$52K	0.0%	-27.9%	0.056%
11/15/2024	Jane Street Group LLC	27,231	$32K	0.0%	-65.8%	0.035%
11/15/2024	Jacobs Levy Equity Management Inc.	1,524,076	$1.80M	0.0%	+1.1%	1.947%
11/15/2024	Janus Henderson Group PLC	4,809,518	$5.70M	0.0%	-23.7%	6.146%
11/13/2024	FMR LLC	284,307	$0.34M	0.0%	+17.3%	0.363%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	280,593	$0.33M	0.0%	+10.4%	0.359%
11/6/2024	Cornercap Investment Counsel Inc.	41,458	$49K	0.0%	-48.6%	0.053%
10/28/2024	US Bancorp DE	33,792	$40K	0.0%	N/A	0.043%
10/23/2024	Assenagon Asset Management S.A.	1,644,168	$1.94M	0.0%	+32.8%	2.110%
10/9/2024	Congress Park Capital LLC	1,216,008	$1.44M	0.5%	+5.4%	1.561%
9/16/2024	Cubist Systematic Strategies LLC	82,054	$100K	0.0%	+96.6%	0.105%
8/16/2024	Forefront Analytics LLC	64,065	$78K	0.0%	+206.7%	0.082%
8/14/2024	Squarepoint Ops LLC	198,840	$0.24M	0.0%	-22.7%	0.255%
8/14/2024	Cubist Systematic Strategies LLC	82,054	$100K	0.0%	+96.6%	0.105%
8/13/2024	Sei Investments Co.	382,723	$0.47M	0.0%	N/A	0.491%
8/12/2024	XTX Topco Ltd	60,586	$74K	0.0%	+382.6%	0.078%
8/9/2024	Renaissance Technologies LLC	1,183,022	$1.44M	0.0%	-4.0%	1.518%
8/6/2024	Acadian Asset Management LLC	2,728,569	$3.32M	0.0%	+1.4%	3.502%
8/6/2024	Candriam S.C.A.	210,027	$0.26M	0.0%	N/A	0.270%
7/18/2024	Assenagon Asset Management S.A.	1,238,499	$1.51M	0.0%	+206.0%	1.589%
7/12/2024	Congress Park Capital LLC	1,153,220	$1.41M	0.6%	+393.3%	1.480%
5/17/2024	Tidal Investments LLC	288,101	$0.63M	0.0%	-5.9%	0.370%
5/16/2024	Jacobs Levy Equity Management Inc.	529,935	$1.16M	0.0%	-33.0%	0.680%
5/10/2024	Acadian Asset Management LLC	2,690,830	$5.86M	0.0%	+1.7%	3.949%
5/10/2024	Vanguard Group Inc.	4,857,374	$10.59M	0.0%	-0.9%	7.129%
5/7/2024	Susquehanna Fundamental Investments LLC	56,745	$0.12M	0.0%	N/A	0.083%
5/7/2024	SG Americas Securities LLC	26,114	$57K	0.0%	N/A	0.038%
4/16/2024	Congress Park Capital LLC	233,800	$0.51M	0.2%	-2.3%	0.345%
2/15/2024	Forefront Analytics LLC	30,846	$48K	0.0%	-37.6%	0.046%
2/7/2024	Formidable Asset Management LLC	306,107	$0.47M	0.1%	-3.8%	0.457%
1/19/2024	Congress Park Capital LLC	239,300	$0.37M	0.2%	+112.8%	0.357%
1/19/2024	AlphaMark Advisors LLC	23,183	$36K	0.0%	+119.8%	0.035%
1/17/2024	Assenagon Asset Management S.A.	404,674	$0.63M	0.0%	-5.0%	0.604%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	145,934	$0.19M	0.0%	-6.5%	0.218%
11/6/2023	Assenagon Asset Management S.A.	425,921	$0.55M	0.0%	-36.2%	0.638%
10/24/2023	Bank of New York Mellon Corp	266,836	$0.34M	0.0%	+737.4%	0.400%
8/8/2023	Bronte Capital Management Pty Ltd.	925,245	$1.59M	0.2%	+0.8%	1.395%
7/14/2023	Congress Park Capital LLC	106,150	$0.18M	0.1%	+5.9%	0.160%
5/12/2023	Tejara Capital Ltd	157,928	$0.24M	0.1%	-33.1%	0.238%
5/11/2023	Cornercap Investment Counsel Inc.	82,415	$0.12M	0.0%	-44.4%	0.124%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	134,309	$0.20M	0.0%	-11.1%	0.202%
5/1/2023	Virtu Financial LLC	24,136	$36K	0.0%	N/A	0.036%
4/20/2023	Congress Park Capital LLC	100,200	$0.15M	0.1%	N/A	0.151%
4/18/2023	Assenagon Asset Management S.A.	668,032	$1.01M	0.0%	-27.0%	1.009%
2/15/2023	Tang Capital Management LLC	3,510,445	$5.62M	0.8%	+0.3%	5.312%
2/13/2023	Platinum Investment Management Ltd.	635,798	$1.02M	0.0%	-48.3%	0.962%
2/13/2023	Forefront Analytics LLC	24,787	$40K	0.0%	-48.2%	0.038%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	151,020	$0.24M	0.0%	-28.3%	0.229%
2/9/2023	CM Management LLC	75,000	$0.12M	0.1%	N/A	0.113%
2/7/2023	Commonwealth Equity Services LLC	53,243	$85K	0.0%	N/A	0.081%
2/7/2023	Formidable Asset Management LLC	318,233	$0.51M	0.1%	+2.2%	0.482%
2/1/2023	Bank of Montreal Can	69,600	$0.12M	0.0%	N/A	0.105%
1/12/2023	Assenagon Asset Management S.A.	914,900	$1.46M	0.0%	-14.1%	1.384%
1/10/2023	FNY Investment Advisers LLC	65,000	$0.10M	0.1%	N/A	0.098%
11/23/2022	Toroso Investments LLC	311,315	$0.45M	0.0%	+49.8%	0.471%
11/15/2022	Tang Capital Management LLC	3,500,000	$5.08M	0.6%	+231.9%	5.296%
11/15/2022	Formidable Asset Management LLC	311,315	$0.45M	0.1%	+49.8%	0.471%
11/15/2022	BVF Inc. IL	6,595,801	$9.56M	0.4%	+13.6%	9.982%
11/14/2022	Ergoteles LLC	279,056	$0.41M	0.0%	-12.2%	0.422%
11/14/2022	Forefront Analytics LLC	47,869	$71K	0.0%	+33.3%	0.072%
11/9/2022	Magnus Financial Group LLC	20,000	$29K	0.0%	N/A	0.030%
11/8/2022	AlphaCentric Advisors LLC	257,500	$0.37M	0.4%	N/A	0.390%
11/4/2022	Russell Investments Group Ltd.	61,320	$88K	0.0%	-74.0%	0.093%
10/27/2022	Assenagon Asset Management S.A.	1,065,392	$1.55M	0.0%	N/A	1.615%
8/16/2022	Formidable Asset Management LLC	207,772	$0.38M	0.1%	N/A	0.315%
8/15/2022	Clearline Capital LP	196,583	$0.36M	0.0%	+3.1%	0.298%
8/15/2022	Point72 Asset Management L.P.	2,750,000	$5.03M	0.0%	-37.1%	4.170%
8/15/2022	Laurion Capital Management LP	1,270,900	$2.33M	0.0%	N/A	1.927%
8/15/2022	Knightsbridge Asset Management LLC	96,926	$0.18M	0.0%	N/A	0.147%
8/11/2022	Platinum Investment Management Ltd.	1,229,545	$2.25M	0.1%	+25.5%	1.864%

Data available starting January 2016

See Full Table

CytomX Therapeutics, Inc., an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines; and PROBODY platform in preclinical research in areas outside of oncology. It also develops CX-904, a T-cell-engaging bispecific antibody targeting the epidermal growth factor receptor (EGFR) on tumor cells and the CD3 receptor on T cells; CX-2051, a conditionally activated ADC for optimizing the therapeutic index for EpCAM-expressing epithelial cancers, including colorectal cancer; and CX-801, an interferon alpha-2b PROBODY cytokine. In addition, the company's development pipeline comprises CX-2029, a conditional activated ADC targeting CD71; and BMS-986288, a PROBODY version of non-fucosylated ipilimumab. It has strategic collaborations with Amgen, Astellas, Bristol Myers Squibb, Regeneron, and Moderna. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.

Today's Range

Now: $0.47

$0.43

$0.47

50 Day Range

MA: $0.69

$0.43

$0.94

52 Week Range

Now: $0.47

$0.40

$5.85

Volume

338,058 shs

Average Volume

2,648,616 shs

Market Capitalization

$37.49 million

P/E Ratio

2.74

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of CytomX Therapeutics?: CytomX Therapeutics' top insider investors include:
Sean A Mccarthy (CEO)
Marcia Belvin (SVP)
Christopher Ogden (CFO)
Yu-Waye Chu (Insider)
Lloyd A Rowland (General Counsel)
Jeffrey B Landau (Insider)
Christopher Ogden (SVP)
Learn More about top insider investors at CytomX Therapeutics.